XML 21 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
11 Months Ended 12 Months Ended
Dec. 31, 2010
Dec. 31, 2011
Dec. 31, 2009
Cash flows from operating activities:      
Net income (loss) $ (69,142) $ 7,872 $ 54,099
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:      
Depreciation and amortization 8,556 10,687 5,033
Amortization of intangibles 3,773 5,189 0
Amortization of deferred financing costs 1,813 1,055 0
Change in deferred income tax 47,337 1,155 (40,517)
Excess tax benefits relating to employee stock compensation 0 0 (120)
Compensation under stock-based compensation plans 3,320 4,466 3,419
Loss on disposal of fixed assets 350 404 0
Loss on extinguishment of debt 9,561 0 0
Changes in assets and liabilities, net of acquired business:      
Receivables, net of bad debt expense (4,321) (31,690) 7,536
Inventory (11,021) 9,777 (6,029)
Prepaid expenses and other assets (9,907) 8,433 (1,237)
Accounts payable 2,944 (1,659) (2,401)
Claims payable (1,030) 8,729 (1,162)
Amounts due to plan sponsors 6,079 5,437 (708)
Accrued interest 5,766 59 0
Accrued expenses and other liabilities (15,497) (2,945) 4,832
Net cash provided by operating activities (21,419) 26,969 22,745
Cash flows from investing activities:      
Purchases of property and equipment, net (10,850) (9,444) (5,739)
Cash consideration paid to CHS, net of cash acquired (92,464) 0 0
Cash consideration paid to DS Pharmacy (4,969) 0 0
Cash consideration paid for asset acquisitions 0 (463) 0
Net cash used in investing activities (108,283) (9,907) (5,739)
Cash flows from financing activities:      
Cash consideration paid for Option Health earn-out (1,000) 0 0
Proceeds from new credit facility, net of fees paid to issuers 319,000 0 0
Borrowings on line of credit 407,277 1,773,644 1,331,000
Repayments on line of credit (356,430) (1,791,058) (1,351,022)
Repayments of capital leases (348) (2,635) 0
Principal payments on CHS long-term debt, paid at closing (128,952) 0 0
Principal payments on long-term debt (100,000) 0 0
Repayment of note payable (2,250) 0 0
Deferred and other financing costs (11,583) (22) 0
Net proceeds from exercise of employee stock compensation plans 4,116 3,198 3,015
Excess tax benefits relating to employee stock compensation 0 0 120
Surrender of stock to satisfy minimum tax withholding (128) (189) (119)
Net cash (used in) provided by financing activities 129,702 (17,062) (17,006)
Net change in cash and cash equivalents 0 0 0
Cash and cash equivalents - end of period   0 0
Cash and cash equivalents - end of period 0 0 0
DISCLOSURE OF CASH FLOW INFORMATION:      
Cash paid during the period for interest 20,116 27,528 1,918
Cash paid during the period for income taxes, net of refunds 2,565 1,042 741
Capital lease obligations incurred to acquire property and equipment $ 671 $ 6,631 $ 0